Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Adam Friedman MD, FAAD

Adam Friedman MD, FAAD

Professor and Chair of Dermatology; Residency Program Director; Director of Translational Research; Director of Supportive Oncodermatology, Department of Dermatology, George Washington School of Medicine and Health Sciences, Washington, DC

Adam Friedman, MD, FAAD, is Professor and Chair of Dermatology and serves as Associate Residency Program Director, Director of Translational Research, and Director of the Supportive Oncodermatology Program in the Department of Dermatology at The George Washington University School of Medicine & Health Sciences.

Disclosures

Dr. Friedman is a consultant for Novartis and Regeneron.

Recent Contributions to PracticeUpdate:

  1. Efficacy of Treatment With Intravenous Immunoglobulin in Patients With Pyoderma Gangrenosum
  2. Real-World Clinical, Psychosocial, and Economic Burden of Atopic Dermatitis
  3. Successful Tapering of Dupilumab in Patients With Atopic Dermatitis With Low Disease Activity
  4. Benefits of Complete Response to Treatment in Patients With Chronic Spontaneous Urticaria
  5. Updated Guidelines for Managing Chronic Urticaria
  6. Clinical and Hormonal Profile of Late-Onset and Persistent Acne in Women
  7. The Utilization of Bacterial Cultures in Dermatology

Most Read This Week

Recently Updated